Danaparoid reduces transplant-related mortality in stem cell transplantation for children
Pediatric Transplantation Dec 20, 2017
Kato K, et al. - Herein, the authors examined the effect of danaparoid on the transplant-related mortality (TRM) in stem cell transplantation (SCT) for children. The results illustrated a reduction in TRM after SCT over the time periods. It was disclosed that the supportive care with danaparoid was markedly effective in reducing TRM in SCT for children.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
